ALPHENIX INTERVENTIONAL ANGIOGRAPHY SYSTEM REF: INFX-8000F
Published November 4, 2026 · Recall initiated: October 12, 2026
Summary
FDA records medical device Class II recall Z-0290-2027, published November 4, 2026 and initiated October 12, 2026. Recalling firm: Canon Medical System, USA, INC.; Status: Ongoing; Reported quantity: 3 units; Lot: DI-04987670100208/. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Due to software issue, X-ray interventional system may experience internal error if F-Store or imagine acquisition is performed while clinical analysis function is use.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Canon Medical System, USA, INC.
- Distributor
- US Nationwide distribution in the states of AL, AR, AZ, CA, FL, GA, HI, IL, LA, MA, MI, MN, MS, NC, NV, OH, OR, TX.
- Lot
- DI-04987670100208/
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAALPHENIX INTERVENTIONAL ANGIOGRAPHY SYSTEM REF: INFX-8000VNovember 4, 2026
- FDAALPHENIX INTERVENTIONAL ANGIOGRAPHY SYSTEM REF: INFX-8000CNovember 4, 2026
- FDAModel Number: 712010.November 4, 2026
- FDAPhilips Azurion 3 M12. Model Numbers: 722063, 722221.November 4, 2026
- FDAAlphenix INFX-8000C/B5October 14, 2026
- FDAAlphenix Models INFX-8000C INFX-8000F INFX-8000V This device is a digital radiography/fluoroscopy system usedSeptember 2, 2026
Questions about this recall
Was ALPHENIX INTERVENTIONAL ANGIOGRAPHY SYSTEM REF: INFX-8000F recalled?
Yes. FDA published recall Z-0290-2027 on November 4, 2026. Reported hazard: Due to software issue, X-ray interventional system may experience internal error if F-Store or imagine acquisition is performed while clinical analysis function is use.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail